Contact Information

605, SGH,
Vaishali Nagar, Jaipur, Rajasthan - 302021

We're Available 24/7. Call Now.

Cyril Amarchand Mangaldas advised the promoters of Suven Pharmaceuticals Limited (Suven Pharmaceuticals) in relation to the acquisition of Suven Pharmaceuticals by global private equity firm Advent, for an aggregate amount of INR 9,500 crore (approx.) through a share purchase agreement for c. 51% followed by an open offer for 26%.

The General Corporate and Competition Law Practices of Cyril Amarchand Mangaldas acted as the legal counsel for promoters of Suven Pharmaceuticals on the transaction. The scope of work included undertaking vendor due diligence exercise, carrying out drafting, negotiations, review and finalisation of the share purchase agreement and ancillary agreements. The transaction team was led by Shishir Vayttaden, Partner; with support from Reeti AgarwalAssociate; Raksha Raina, Associate; Kashish Mahajan, Associate; Saumya Sharma, Associate; and Tawishi BeriaAssociateBhargav Joshi, Partner assisted with the due diligence exercise.

The Real Estate team was led by Namrata KolarPartner (Co-head-Real Estate); with support from Jaideep Kodali, Principal Associate.

Pharma and Life Sciences team was led by Biplab LeninPartner; with support from Kartik Jain, Senior Associate.

Avaantika KakkarPartner (Head-Competition Law); advised on the competition law related aspects of the transaction.

As a part of the Transaction, Advent, has agreed to buy out a majority in Suven Pharmaceuticals Limited from our clients. Advent will also make an open offer to acquire 26% shares from public shareholders.

Other Parties and Advisors to the transaction included Barclays (acted as banker for the sellers).

The transaction was signed on 26th December 2022.



NewsOnFloor Staff's knowledge of Bollywood film industry is tremendous and their writing attracts all the cinema lovers. Team follows everything which is happening on the bollywood street .

Leave A Reply

Your email address will not be published. Required fields are marked *